Skip to contentC
Chemed Corp
C
CHEChemed Corp Q2 2019 · 10-Q
Revenue$473.58M$473.58M+7.2% vs Q2 2018 Net Income$50.73M$50.73M−7.7% vs Q2 2018 EPS Diluted$3.08$3.08−5.8% vs Q2 2018 Operating Income$65,528,000+12.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$20,876,000−53.2% Margins · derivedOperating margin13.8%+0.7 pt vs Q2 2018
Net margin10.7%−1.7 pt vs Q2 2018
ended Jun 30, 2019 · filed Jul 31, 2019 · 31 d after period end